Cross Country Healthcare (CCRN)
(Delayed Data from NSDQ)
$12.33 USD
+0.15 (1.23%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $12.33 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$12.33 USD
+0.15 (1.23%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $12.33 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth A Momentum A VGM
Zacks News
Here's Why Investor Should Hold S&P Global (SPGI) Stock Now
by Zacks Equity Research
Strategic acquisitions as well as pro-investor steps boost S&P Global (SPGI).
Here's Why Investors Should Retain Genpact (G) Stock Now
by Zacks Equity Research
Investor-friendly steps and strong clientele boost Genpact (G) stock.
Here's Why One Should Hold Automatic Data Processing (ADP) Now
by Zacks Equity Research
Strong business model as well as its three-tier business strategy boost Automatic Data Processing (ADP) stock.
Why Booz Allen (BAH) Stock is Up 13% in the Past Six Months
by Zacks Equity Research
Booz Allen's (BAH) VoLT strategy focuses on integrating velocity, leadership and technology in the process of transformation.
Should Invesco S&P SmallCap Value with Momentum ETF (XSVM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for XSVM
Cross Country Healthcare (CCRN) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Cross Country Healthcare (CCRN) closed at $26.54, marking a -1.63% move from the previous day.
Why You Should Retain Stericycle (SRCL) in Your Portfolio Now
by Zacks Equity Research
Stericycle (SRCL) is currently benefiting from its comprehensive multiyear Business Transformation as well as solid liquidity.
Here's Why Investors Should Retain Accenture (ACN) Stock Now
by Zacks Equity Research
Accenture (ACN) is benefitting from its cloud capabilities, acquisitions as well as consulting businesses.
Is Cross Country Healthcare (CCRN) Stock Outpacing Its Business Services Peers This Year?
by Zacks Equity Research
Here is how Cross Country Healthcare (CCRN) and Clean Harbors (CLH) have performed compared to their sector so far this year.
Waste Connections (WCN) Gains 12.7% in 6 Months: Here's How
by Zacks Equity Research
Waste Connections (WCN) is benefiting from acquisitions, operating efficiency and an increase in prices charged to customers.
Gartner (IT) Gains 34% in the Past 6 Months: Here's How
by Zacks Equity Research
Gartner research reports are indispensable tools for diverse companies across different sectors.
Reasons to Retain FLEETCOR (FLT) Stock in Your Portfolio
by Zacks Equity Research
The acquisition of Accrualify is expected to strengthen FLEETCOR's (FLT) portfolio of payment solutions and its corporate payments platform capabilities.
Reasons to Add Harte Hanks (HHS) Stock to Your Portfolio
by Zacks Equity Research
Harte Hanks (HHS) is currently investing in sales, marketing, technology and partnerships for sustainable growth.
Here's Why Investors Should Hold DocuSign (DOCU) Stock Now
by Zacks Equity Research
eSignature strength as well as solid liquidity boost DocuSign (DOCU).
Why Booz Allen (BAH) Stock Gained 25.4% in the Past Year
by Zacks Equity Research
Vision 2020, differentiated business & large addressable market boost Booz Allen (BAH) stock.
Why Avis Budget (CAR) Stock Gained 40.2% in the Past 3 Months
by Zacks Equity Research
Enhanced technology, connected vehicles fleet & pro-investor steps boost Avis Budget (CAR) stock.
Waste Management (WM) Up 7.5% in the Past 6 Months: Here's Why
by Zacks Equity Research
Shareholder-friendly steps as well as advanced waste collection and recycling techniques boost Waste Management (WM).
Accenture (ACN) Announces the Acquisition of Fiftyfive5
by Zacks Equity Research
Fiftyfive5's addition is expected to strengthen Accenture's (ACN) capabilities across product innovation, commerce, marketing, sales and service.
Reasons Why You Should Bet on Gambling.com (GAMB) Stock Now
by Zacks Equity Research
Gambling.com (GAMB) has a strong operating model that is helping it to derive healthy margins and free cash inflow consistently.
Automatic Data Processing (ADP) Seems Promising: Here's Why
by Zacks Equity Research
Strong business model, high recurring revenues, good margins and robust client retention boost Automatic Data Processing (ADP) stock.
Here's Why You Should Hold ABM Industries (ABM) Stock Now
by Zacks Equity Research
Strategic acquisitions as well as pro-investor steps boost ABM Industries (ABM).
Accenture (ACN) Announces Velocity Co-developed With AWS
by Zacks Equity Research
Velocity enables clients to quickly accept Accenture (ACN) and AWS innovations based on learnings from several projects.
Charles River (CRAI) Announces bioStrategies Acquisition
by Zacks Equity Research
The acquisition expands Charles River's (CRAI) geographic presence and adds to its already strong team of highly qualified senior officials.
Here's Why Investors Should Retain Accenture (ACN) Stock Now
by Zacks Equity Research
Cloud capabilities as well as consulting businesses boost Accenture (ACN).
Here's Why Investors Should Retain Genpact (G) Stock Now
by Zacks Equity Research
Strong clientele and shareholder-friendly measures boost Genpact (G).